AustraliaAn article discusses how New Zealand's approval of the herbicide glyphosate, used in products like Roundup, relies on industry-funded reviews that are now under investigation. Following a U.S. Supreme Court ruling in favor of Bayer, which acquired Monsanto, the legal battle over glyphosate's cancer risks continues. The U.S. Environmental Protection Agency (EPA) classifies glyphosate as 'not likely' to cause cancer, whereas the World Health Organization's International Agency for Research on Cancer (IARC) labels it 'probably carcinogenic to humans.' This discrepancy arises because the EPA often relies on unpublished studies funded by manufacturers, while IARC uses publicly available data. New Zealand, unable to assess all chemicals independently, depends on international evaluations. However, some of these assessments were influenced by Monsanto, including ghostwritten reports and studies with questionable integrity. Recent investigations into these reviews suggest potential flaws in the regulatory process, raising concerns about the reliability of industry-backed scientific assessments.
Bias read (Progressive): The article frames the issue as a conflict between industry-funded research and independent scientific standards, highlighting the influence of corporate interests on regulatory decisions. It emphasizes the ethical concerns surrounding ghostwriting and data fabrication, aligning more closely with a左
